BV100 Philippines trial plans list two hospitals. Witfire checks RIV-TARGET, revised readout dates, the antibiotic regimen and pending local recruitment.
Nerandomilast Philippines trial plans name three hospitals. Inside the Phase 3 systemic sclerosis study, its evidence, endpoints and pending local recruitment.
Philippine FDA CPR renewal guidance confirms when an expired medical-device CPR remains valid during review and which records ...
The ravulizumab ARTEMIS trial has been terminated at 555 patients. Read alone it is one failed study. Read against the registry it is the sixth attempt to take a rare-disease drug into a large ...
Alevia-B is receiving fresh coverage in the Philippines through PascualLab’s 80th-anniversary portfolio campaign. Each tablet combines paracetamol with vitamins B1, B6 and B12. The Philippine FDA ...
RENGEVITY-201 trial begins Phase 2 testing of pegrizeprument against tacrolimus in kidney transplantation. We examine its ...
Bright scientific image illustrating eplontersen TTR silencing in transthyretin amyloid cardiomyopathy, cardiac amyloid burden and the challenge of adding a silencer to stabilizer therapy. HELIOS-B ...
AlzeCure did not prove ACD856 works in Alzheimer’s patients. It proved that early safety, brain exposure and a novel mechanism can still move a small Nordic biotech into a multibillion-dollar ...
Bright biotech illustration for Unicycive’s OLC CRL, showing nanoparticle formulation, manufacturing control strategy, FDA quality risk and CDMO execution failure. No safety concern. No efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results